Prescription drug · ANDA
Mesna NDC 25021-201
Mesna 100 mg/mL · Injection, Solution · Intravenous · Sagent Pharmaceuticals
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 25021-201-10 | 25021020110 | 1 VIAL in 1 CARTON (25021-201-10) / 10 mL in 1 VIALMarketed from Dec 1, 2010 | |
| 25021-201-11 | 25021020111 | 10 VIAL in 1 CARTON (25021-201-11) / 10 mL in 1 VIALMarketed from Dec 1, 2010 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Mesna
- Generic name (nonproprietary)
- mesna
- Active ingredients
- Mesna — 100 mg/mL
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Labeler
- Sagent PharmaceuticalsNDC labeler code 25021
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 090913
- Marketing start
- Listing expires
- Identifiers
- Product ID 25021-201_b216cb2c-ff72-4b54-9486-404a23092128SPL ID b216cb2c-ff72-4b54-9486-404a23092128SPL set ID 2a2a526f-636b-7920-4261-6c626f612a2aRxCUI 204870UNII NR7O1405Q9
- Pharmacologic class
- Cytoprotective Agent
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N425021020110followed by a unit qualifier and the quantityPackage 25021-0201-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Mesna Injection is indicated as a prophylactic agent in reducing the incidence of ifosfamide-induced hemorrhagic cystitis. Mesna Injection is a cytoprotective agent indicated as a prophylactic agent in reducing the incidence of ifosfamide-induced hemorrhagic cystitis. ( 1 ) Limitation of Use: Mesna Injection is not indicated to reduce the risk of hematuria due to other pathological conditions such as thrombocytopenia. ( 1 ) Limitation of Use: Mesna Injection is not indicated to reduce the risk of hematuria due to other pathological conditions such as thrombocytopenia.
Excerpt only. Read the full label for complete information.
About NDC 25021-201
- What is NDC 25021-201?
- 25021-201 is the product NDC for Mesna, Mesna 100 mg/mL injection, solution, listed with the FDA by Sagent Pharmaceuticals. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Mesna.
- What is the active ingredient?
- Mesna.
- Who is the labeler?
- Sagent Pharmaceuticals, NDC labeler code 25021. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Mesna?
- 7 other product NDCs are listed under this name. See all Mesna NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Mesna products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Mesna | Mesna 100 mg/mL | Injection, SolutionIntravenous | Eugia US LLC | 55150-520 | 55150-0520-01 |
| Mesna | Mesna 400 mg/1 | Tablet, Film coatedOral | Ingenus Pharmaceuticals, LLC | 50742-354 | 50742-0354-01 |
| Mesnamesna injection | Mesna 100 mg/mL | SolutionIntravenous | Gland Pharma Limited | 68083-161 | 68083-0161-0168083-0161-10 |
| mesna | Mesna 100 mg/mL | Injection, SolutionIntravenous | Hikma Pharmaceuticals USA Inc. | 0143-9260 | 00143-9260-01 |
| Mesna | Mesna 100 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 63323-733 | 63323-0733-1063323-0733-11 |
| Mesna | Mesna 100 mg/mL | Injection, SolutionIntravenous | Baxter Healthcare Company | 10019-951 | 10019-0951-05 |
| Mesna | Mesna 100 mg/mL | Injection, SolutionIntravenous | Baxter Healthcare Company | 10019-953 | 10019-0953-0110019-0953-02 |